InChI key
OUPZKGBUJRBPGC-UHFFFAOYSA-N
InChI
1S/C12H15N3O6/c16-10-13(1-7-4-19-7)11(17)15(3-9-6-21-9)12(18)14(10)2-8-5-20-8/h7-9H,1-6H2
SMILES string
O=C1N(CC2CO2)C(=O)N(CC3CO3)C(=O)N1CC4CO4
form
powder
Quality Level
正在寻找类似产品? 访问 产品对比指南
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Muta. 1B - Skin Sens. 1 - STOT RE 2
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
U Erikstam et al.
Contact dermatitis, 44(1), 13-17 (2001-01-13)
Triglycidyl isocyanurate (TGIC) is mainly used in polyester-based powder paints, but also in laminates, insulating varnishes, coatings and adhesives. Several cases of contact allergy to TGIC have been reported during the last 10 years. Contact allergy to TGIC has developed
J Rubin et al.
Cancer treatment reports, 71(5), 489-492 (1987-05-01)
Two schedules of teroxirone, a triazine triepoxide, were evaluated in a phase I study. Twenty-six patients were treated on 1 day every 5 weeks at doses of 36-2250 mg/m2. At doses greater than or equal to 1500 mg/m2, severe thrombophlebitis
Airborne contact dermatitis due to triglycidylisocyanurate.
A Dooms-Goossens et al.
Contact dermatitis, 21(3), 202-203 (1989-09-01)
Occupational contact allergy to triglycidyl isocyanurate (TGIC, Tepic).
K Nishioka et al.
Contact dermatitis, 19(5), 379-380 (1988-11-01)
M M Ames et al.
Cancer research, 44(9), 4151-4156 (1984-09-01)
Teroxirone is an experimental triepoxide antitumor agent currently undergoing evaluation in clinical trials. We have developed an assay based on derivatization with diethyldithiocarbamate followed by normal-phase high-performance liquid chromatographic analysis. When 14C-labeled teroxirone is administered to rabbits by rapid i.v.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持

